A BILL 
To amend section 303(g) of the Controlled Substances Act 
(21 U.S.C. 823(g)) to eliminate the separate registration 
requirement for dispensing narcotic drugs in schedule 
III, IV, or V (such as buprenorphine) for maintenance 
or detoxification treatment, and for other purposes. 
15:43 Mar 24, 2021
H1384
2 
•HR 1384 IH
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Mainstreaming Addic-
4
tion Treatment Act of 2021’’. 
5
SEC. 2. ELIMINATING SEPARATE REGISTRATION REQUIRE-
6
MENT FOR DISPENSING NARCOTIC DRUGS IN 
7
SCHEDULE III, IV, AND V FOR MAINTENANCE 
8
OR DETOXIFICATION TREATMENT. 
9
(a) IN GENERAL.—Section 303 of the Controlled 
10
Substances Act (21 U.S.C. 823) is amended— 
11
(1) by striking paragraph (2) of subsection (g); 
12
and 
13
(2) in subsection (g), as amended— 
14
(A) by striking ‘‘(g)(1) Except as provided 
15
in paragraph (2), practitioners who dispense 
16
narcotic drugs to individuals for maintenance 
17
treatment or detoxification treatment’’ and in-
18
serting ‘‘(g) Practitioners who dispense narcotic 
19
drugs (other than narcotic drugs in schedule 
20
III, IV, or V) to individuals for maintenance 
21
treatment or detoxification treatment’’; 
22
(B) by redesignating subparagraphs (A), 
23
(B), and (C) as paragraphs (1), (2), and (3), 
24
respectively; and 
25
15:43 Mar 24, 2021
H1384
3 
•HR 1384 IH
(C) in paragraph (2), as redesignated, by 
1
redesignating clauses (i) and (ii) as subpara-
2
graphs (A) and (B), respectively. 
3
(b) CONFORMING CHANGES.— 
4
(1) Subsections (a) and (d)(1) of section 304 of 
5
the Controlled Substances Act (21 U.S.C. 824) are 
6
amended by striking ‘‘303(g)(1)’’ each place it ap-
7
pears and inserting ‘‘303(g)’’. 
8
(2) Section 309A(a)(2) of the Controlled Sub-
9
stances Act (21 U.S.C. 829a) is amended— 
10
(A) in the matter preceding subparagraph 
11
(A), by striking ‘‘the controlled substance is to 
12
be administered for the purpose of maintenance 
13
or 
detoxification 
treatment 
under 
section 
14
303(g)(2)’’ and inserting ‘‘the controlled sub-
15
stance is a narcotic drug in schedule III, IV, or 
16
V to be administered for the purpose of mainte-
17
nance or detoxification treatment’’; and 
18
(B) by striking ‘‘and—’’ and all that fol-
19
lows through ‘‘is to be administered by injection 
20
or implantation;’’ and inserting ‘‘and is to be 
21
administered by injection or implantation;’’. 
22
(3) Section 520E–4(c) of the Public Health 
23
Service Act (42 U.S.C. 290bb–36d(c)) is amended 
24
by striking ‘‘information on any qualified practi-
25
15:43 Mar 24, 2021
H1384
4 
•HR 1384 IH
tioner that is certified to prescribe medication for 
1
opioid dependency under section 303(g)(2)(B) of the 
2
Controlled Substances Act’’ and inserting ‘‘informa-
3
tion on any practitioner who prescribes narcotic 
4
drugs in schedule III, IV, or V of section 202 of the 
5
Controlled Substances Act for the purpose of main-
6
tenance or detoxification treatment’’. 
7
(4) Section 544(a)(3) of the Public Health 
8
Service Act (42 U.S.C. 290dd–3) is amended by 
9
striking ‘‘any practitioner dispensing narcotic drugs 
10
pursuant to section 303(g) of the Controlled Sub-
11
stances Act’’ and inserting ‘‘any practitioner dis-
12
pensing narcotic drugs for the purpose of mainte-
13
nance or detoxification treatment’’. 
14
(5) Section 1833(bb)(3)(B) of the Social Secu-
15
rity Act (42 U.S.C. 1395l(bb)(3)(B)) is amended by 
16
striking ‘‘first receives a waiver under section 303(g) 
17
of the Controlled Substances Act on or after Janu-
18
ary 1, 2019’’ and inserting ‘‘first begins prescribing 
19
narcotic drugs in schedule III, IV, or V of section 
20
202 of the Controlled Substances Act for the pur-
21
pose of maintenance or detoxification treatment on 
22
or after January 1, 2021’’. 
23
(6) Section 1834(o)(3)(C)(ii) of the Social Se-
24
curity Act (42 U.S.C. 1395m(o)(3)(C)(ii)) is amend-
25
15:43 Mar 24, 2021
H1384
5 
•HR 1384 IH
ed by striking ‘‘first receives a waiver under section 
1
303(g) of the Controlled Substances Act on or after 
2
January 1, 2019’’ and inserting ‘‘first begins pre-
3
scribing narcotic drugs in schedule III, IV, or V of 
4
section 202 of the Controlled Substances Act for the 
5
purpose of maintenance or detoxification treatment 
6
on or after January 1, 2021’’. 
7
(7) Section 1866F(c)(3) of the Social Security 
8
Act (42 U.S.C. 1395cc–6(c)(3)) is amended— 
9
(A) in subparagraph (A), by inserting 
10
‘‘and’’ at the end; 
11
(B) in subparagraph (B), by striking ‘‘; 
12
and’’ and inserting a period; and 
13
(C) by striking subparagraph (C). 
14
(8) Section 1903(aa)(2)(C) of the Social Secu-
15
rity Act (42 U.S.C. 1396b(aa)(2)(C)) is amended— 
16
(A) in clause (i), by inserting ‘‘and’’ at the 
17
end; and 
18
(B) by striking clause (ii). 
19
SEC. 3. NATIONAL EDUCATION CAMPAIGN. 
20
(a) IN GENERAL.—The Secretary of Health and 
21
Human Services, acting through the Assistant Secretary 
22
for Mental Health and Substance Use, shall conduct a na-
23
tional campaign to educate practitioners with respect to 
24
the elimination of the separate registration requirement 
25
15:43 Mar 24, 2021
H1384
6 
•HR 1384 IH
under section 303(g) of the Controlled Substances Act (21 
1
U.S.C. 823(g)), as in effect on the day before the date 
2
of enactment of this Act, for dispensing narcotic drugs in 
3
schedule III, IV, and V for maintenance or detoxification 
4
treatment. 
5
(b) REQUIRED COMPONENTS.—The national edu-
6
cation campaign under subsection (a) shall— 
7
(1) encourage practitioners to integrate sub-
8
stance use treatment into their practices; and 
9
(2) include education on publicly available edu-
10
cational resources and training modules that can as-
11
sist practitioners in treating patients with a sub-
12
stance use disorder. 
13
SEC. 4. COMMUNITY HEALTH AIDES AND COMMUNITY 
14
HEALTH PRACTITIONERS. 
15
(a) PRACTICE OF TELEMEDICINE.—Section 102 of 
16
the Controlled Substances Act (21 U.S.C. 802) is amend-
17
ed— 
18
(1) in paragraph (54)(A), by striking clause (i) 
19
and inserting the following: 
20
‘‘(i) while the patient is— 
21
‘‘(I) being treated by, and physically 
22
located in, a hospital or clinic registered 
23
under section 303(f); or 
24
15:43 Mar 24, 2021
H1384
7 
•HR 1384 IH
‘‘(II) for purposes of section 302(h), 
1
being treated by a community health aide 
2
or community health practitioner; and’’; 
3
(2) by redesignating paragraph (58) as para-
4
graph (59); 
5
(3) by redesignating the second paragraph des-
6
ignated as paragraph (57) as paragraph (58); 
7
(4) by moving paragraphs (57), (58) (as so re-
8
designated), and (59) (as so redesignated) 2 ems to 
9
the left; and 
10
(5) by adding at the end the following: 
11
‘‘(60) The terms ‘community health aide’ and ‘com-
12
munity health practitioner’ have the meanings given to 
13
such terms for purposes of section 119 of the Indian 
14
Health Care Improvement Act (25 U.S.C. 1616l).’’. 
15
(b) DISPENSATION OF NARCOTIC DRUGS IN SCHED-
16
ULE III, IV, OR V.—Section 302 of the Controlled Sub-
17
stances Act (21 U.S.C. 822) is amended by adding at the 
18
end the following: 
19
‘‘(h) DISPENSATION OF NARCOTIC DRUGS IN SCHED-
20
ULE III, IV, OR V BY CERTAIN PRACTITIONERS.— 
21
‘‘(1) IN GENERAL.—Notwithstanding subsection 
22
(a)(2), a community health aide or community 
23
health practitioner may dispense a narcotic drug in 
24
schedule III, IV, or V, such as buprenorphine, or a 
25
15:43 Mar 24, 2021
H1384
8 
•HR 1384 IH
combination of such drugs, to an individual for 
1
maintenance treatment or detoxification treatment 
2
(or both) without being registered under this title if 
3
the drug is prescribed by a practitioner through the 
4
practice of telemedicine. 
5
‘‘(2) PREEMPTION.—Notwithstanding section 
6
708, a State may not require a community health 
7
aide or community health practitioner to be licensed 
8
by the State in order to dispense narcotic drugs in 
9
accordance with paragraph (1) of this subsection.’’. 
10
Æ 
15:43 Mar 24, 2021
H1384
